DURECT Corp (DRRX) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. AXP
8. DAL
9. VZ
10. SPY

Go back to DURECT Corp (DRRX) Reports In-Line Q3 EPS

DURECT Corporation Announces Third Quarter 2018 Financial Results and Provides Corporate Update

November 7, 2018 4:01 PM EST

CUPERTINO, Calif., Nov. 7, 2018 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended September 30, 2018 and provided a corporate update.  

Total revenues were $8.0 million and net loss was $2.7 million for the three months ended September 30, 2018 as compared to total revenues of $20.7 million and net income of $6.1 million for the three months ended September 30, 2017. The third quarter of 2018 included a $5 million milestone payment from Indivior related to the FDA approval of PERSERIS (risperidone). The third quarter of 2017 included $12.5 million in revenues from the upfront payment... More